首页CRSP • NASDAQ
add
Crispr Therapeutics AG
昨日收盘价
$41.29
当日价格范围
$38.51 - $40.37
年度波幅
$38.20 - $91.10
市值
33.88亿 USD
平均交易量
179.33万
市盈率
-
股息率
-
主要交易所
NASDAQ
财务信息
损益表
收入
净收入
| (USD) | 2024年9月info | 年同比变化 |
|---|---|---|
收入 | 60.20万 | — |
经营支出 | 1741.90万 | -4.77% |
净收入 | -8594.20万 | 23.37% |
净利润率 | -1.43万 | — |
每股收益 | -1.01 | 28.37% |
息税折旧摊销前利润 | -1.05亿 | 17.33% |
有效税率 | -1.03% | — |
资产负债表
总资产
负债总额
| (USD) | 2024年9月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 19.36亿 | 11.26% |
总资产 | 22.56亿 | 8.11% |
负债总额 | 3.16亿 | -11.86% |
权益总额 | 19.40亿 | — |
发行在外的股份 | 8535.35万 | — |
市净率 | 1.82 | — |
资产回报率 | -11.98% | — |
资本回报率 | -12.57% | — |
现金流
现金净变动
| (USD) | 2024年9月info | 年同比变化 |
|---|---|---|
净收入 | -8594.20万 | 23.37% |
来自运营的现金 | -1.07亿 | -168.25% |
投资现金 | -1.62亿 | -233.17% |
融资现金 | 964.00万 | 519.54% |
现金净变动 | -2.59亿 | -411.81% |
自由现金流 | -8067.12万 | -495.63% |
简介
CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases. The company has approximately 500 employees and has offices in Zug, Switzerland, Boston, Massachusetts, San Francisco, California and London, United Kingdom. Its manufacturing facility in Framingham, Massachusetts won the Facilities of the Year Award award in 2022. The company’s lead program, exagamglogene autotemcel, or exa-cel, was granted regulatory approval by the US Food and Drug Administration in December 2023. Wikipedia
成立时间
2013
总部
员工数量
407
